Crohn’s & Colitis News
Below you’ll find our most recent press releases, along with other articles written by the foundation. This media content highlights the public research outcomes related to our initiatives, studies, and clinical trials. In addition, you can read our expert commentary related to research articles culled from external media sources. For a complete list of all our news content, please visit the News Archive section.
If you are a member of the media interested in speaking with a Foundation's spokesperson, contact us today.
Most Recent News
Leading Patient Organizations Collaborate to Improve Patient Care in IBD Through Shared Decision-MakingSeptember 11, 2017
The Crohn’s & Colitis Foundation (Foundation) and the American Gastroenterological Association (AGA),in collaboration with Pfizer, Inc., announced today a request for proposal (RFP), around interventions that aim to improve shared decision-making and promote effective health communication between patients with inflammatory bowel disease (IBD) and their clinicians. The goal is to identify and/or establish best practices around shared decision-making that can be easily replicated, broadly disseminated, and widely adopted within the IBD community.
The Crohn’s & Colitis Foundation released the following statement today after the New York State Senate passed the Crohn’s & Colitis Fairness Act (S3295).
The Crohn’s & Colitis Foundation (the Foundation) is pleased to announce seven new members of its National Board of Trustees, which oversees the management of the organization’s policies, practices, principles, affairs, funds, and property.
Crohn’s & Colitis Foundation & American Gastroenterological Association Partner to Address Effective Patient-Provider Health Communication in the IBD CommunityApril 11, 2017
The Crohn’s & Colitis Foundation (the Foundation) and the American Gastroenterological Association (AGA), in collaboration with Pfizer, Inc., announced today a partnership to develop a program to jumpstart advances in the area of shared decision-making in inflammatory bowel diseases (IBD). The program aims to identify gaps in effective communication and the lack of research on how providers and patients can make decisions together and prevent suboptimal treatment.
Crohn’s & Colitis Foundation and ReachMD Partner to Deliver Educational Information to Healthcare ProfessionalsMarch 21, 2017
The Crohn’s & Colitis Foundation, the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD), and ReachMD®, the nation’s largest medical education learning platform for healthcare professionals, have partnered to deliver exclusive content to ReachMD learners.
Crohn’s & Colitis Foundation and American Gastroenterological Association Announce Conference PartnershipMarch 9, 2017
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) announced today that they are partnering to co-sponsor the first-ever “Crohn’s & Colitis Congress,” which will take place in Las Vegas in January 2018.
Crohn’s & Colitis Foundation RISK Stratification Study Reveals Potential New Approach to Precision Medicine for Pediatric PatientsMarch 2, 2017
Researchers have successfully identified biological signatures in pediatric patients with newly diagnosed Crohn’s disease (CD) capable of predicting whether a child will develop disease-related complications requiring major surgery within three to five years. The results of this research, “Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study,” have been published today in the high impact factor journal, The Lancet.